NCT06952764View on ClinicalTrials.gov

Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE)

NAEnrolling by invitationINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

December 31, 2028

Conditions
Epilepsy (Treatment Refractory)
Interventions
OTHER

Seizure risk forecast

Participants are provided with daily risk estimates about upcoming seizure likelihood.

OTHER

Control seizure risk forecast

Participant receive uninformative control forecast

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER